EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Wnt/β-catenin signaling in hepatocellular carcinoma: a key player in resistance to targeted and immunotherapies

Changmo Park iD, Tin Lok Wong iD, Stephanie Ma iD

Carcinogenesis · 07.07.2026 · 47 (3)

DOI: 10.1093/carcin/bgag040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Carcinogenesis, online erschienen am 04.06.2026. Verfasst von Changmo Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Drug Resistance, Neoplasm, Wnt Signaling Pathway. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Grants Council of Hong Kong, Croucher Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC), accounting for nearly 90% of primary liver cancers, remains a major global health challenge due to late diagnosis and therapy resistance. Up to 50% of cases exhibit aberrant activation of the canonical Wnt/β-catenin pathway, driven by CTNNB1 mutations or inactivating alterations in AXIN1, adenomatous polyposis coli, or ZNRF3, which are mutually exclusive. This hyperactivation has complex implications: it has been associated with drug resistance, larger tumors, epithelial–mesenchymal transition, vascular invasion, cancer stemness, and immune evasion, yet in some contexts, it correlates with a less aggressive, well-differentiated phenotype and improved survival. This heterogeneity highlights the need for further research to clarify its prognostic significance. This review explores recent mechanisms by which aberrant nuclear β-catenin accumulation fosters resistance to frontline tyrosine kinase inhibitors like sorafenib and lenvatinib through ferroptosis evasion, cancer stemness, and β-catenin stabilization. It also highlights how hyperactivated Wnt/β-catenin promotes an immunosuppressive “cold” tumor microenvironment, impairing immunotherapy efficacy. These include cytokine profile alterations, CD8+ T-cell exclusion, dendritic cell repression, and recruitment of immunosuppressive cells such as myeloid-derived suppressor cells, tumor-associated neutrophils, macrophages, and regulatory T cells. Recent preclinical studies show that combining Wnt inhibitors with immunotherapy or tyrosine kinase inhibitors can reprogram the tumor microenvironment, restore ferroptosis sensitivity, eradicate cancer stem cells, enhance CD8+ T-cell infiltration, boost antitumor immunity, and overcome resistance with minimal side effects. Targeting the Wnt/β-catenin pathway offers a promising strategy to transform HCC treatment and improve outcomes by exploiting this pathway as a key therapeutic vulnerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularDrug Resistance, NeoplasmWnt Signaling PathwayImmunotherapyHumansbeta CateninTumor MicroenvironmentAnimalsEpithelial-Mesenchymal TransitionMolecular Targeted Therapy

Stichwörter der Autor:innen

HCCWnt/β-catenin pathwaycancer stemnesscytokineferroptosisimmune checkpoint inhibitorimmune evasiontherapy resistancetumor microenvironmenttyrosine kinase inhibitor

Substanzen

beta Catenin

Autor:innen und Institutionen

  • School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Changmo Park, Tin Lok Wong, Stephanie Ma

Förderung

  • Research Grants Council of Hong Kong
  • Croucher Foundation

Zitieren

APA

Park, C., Wong, T. L., & Ma, S. (2026). Wnt/β-catenin signaling in hepatocellular carcinoma: a key player in resistance to targeted and immunotherapies. Carcinogenesis, 47(3). https://doi.org/10.1093/carcin/bgag040

Vancouver

Park C, Wong TL, Ma S. Wnt/β-catenin signaling in hepatocellular carcinoma: a key player in resistance to targeted and immunotherapies. Carcinogenesis. 2026;47(3). doi:10.1093/carcin/bgag040

BibTeX
@article{Park2026,
  author = {Park, Changmo and Wong, Tin Lok and Ma, Stephanie},
  title = {Wnt/β-catenin signaling in hepatocellular carcinoma: a key player in resistance to targeted and immunotherapies},
  journal = {Carcinogenesis},
  year = {2026},
  volume = {47},
  number = {3},
  doi = {10.1093/carcin/bgag040}
}
Kostenlos starten →